About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Liver Disease Clinical Trials | 203 Studies Recruiting

Clinical TrialsLiver Disease

Liver Disease Clinical Trials

Browse 203 clinical trials for liver disease. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 203 trials

RecruitingMetabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMIThe aim of the prospective observational DISTEMI-Study in people with and without Diabetes mellitus (DI) after new onset of ST-Segment Elevation Myocardial Infarction (STEMI) aged…NCT05046483·Düsseldorf, North Rhine-Westphalia CompletedEvaluating the Pharmacokinetics and Safety of MiricorilantA Phase 1b, Open-Label Study Evaluating the Pharmacokinetics and Safety of Miricorilant in Adult Patients With Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)NCT07553663·San Antonio, Texas UnknownNon Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases SeverityThe aims of this study are to assess the performance of the non-invasive Electrical Impedance Technology (EIT) in evaluating the liver fibrosis stage in patients with chronic…NCT03492879 UnknownA Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver FibrosisThis is a randomized, double-blind, placebo-controlled, parallel-dosing, multi-center study to evaluate the efficacy and safety of Rencofilstat as evidenced by histopathological…NCT05402371·Huntsville, Alabama and 40 others

Related Searches

cirrhosistrials nafldtrials

Data from ClinicalTrials.govTerms

CompletedDevelopment of a Breath Test for Monitoring Patients With Liver DiseaseThe purpose of this study is to determine the safety and efficacy of the Oridion Breath ID machine in monitoring liver metabolic functions.NCT00244569·Richmond, Virginia

RecruitingCardiac Dysfunction in Patients with Fatty Liver DiseaseCirrhotic cardiomyopathy is seen as a blunted contractile responsiveness to stress, and/or altered diastolic relaxation with electrophysiological abnormalities, in absence of…NCT06386094·Chandigarh, Chandigarh

RecruitingA Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic OutcomesTo establish a cohort of elderly fatty liver disease based on the community medical examination population.NCT07241195·Hangzhou, Zhejiang

RecruitingA Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese PatientsThe aim of the study is to demonstrate the superiority of bariatric surgery on the disappearance of NASH without worsening of fibrosis in comparison to medical standard treatment…NCT03472157·Lille

TerminatedRollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic SteatohepatitisThis rollover study will provide open-label treatment with cenicriviroc and will assess the long-term safety of continued treatment with cenicriviroc in participants who…NCT03059446·Dothan, Alabama and 70 others

CompletedPhase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control SubjectsThe purpose of this study is to directly characterize the pharmacokinetic (PK) profiles of MGL-3196 and its major metabolite (MGL-3623) following administration of multiple oral…NCT04643795·Orlando, Florida and 2 others

CompletedAnti-Fibrotic Effects of Losartan In Nash Evaluation StudyThis is a randomized, controlled trial to determine whether Losartan is effective at slowing down, halting or reversing liver fibrosis in patients with non-alcoholic…NCT01051219·Plymouth, Devon and 9 others

Not yet recruitingTHE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)The main objective of this cohort study is to determine genetic, clinical biologic and metabolic factors associated with patient heterogeneity in regards to severity of NAFLD at…NCT04925362

CompletedNon-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology ConsultationEarly screening and monitoring of chronic liver diseases in hepatology practice has become crucial.NCT04782050·Pessac

CompletedCombination Diagnostic Strategies in NAFLDSerial combination of biological and elastography tests is accurate to diagnosing advanced fibrosis in non-alcoholic fatty liver disease (NAFLD) patients.NCT04384159

CompletedNAFLD and Liver Fibrosis in Obese AdolescentsNonalcoholic fatty liver disease (NAFLD) is a chronic liver disease resulting from excessive fat accumulation in the liver.NCT04561804·Tel Aviv

UnknownDapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.The role of Dapagliflozin in the improvement in CKD in both diabetic and non-diabetic patients has been evaluated in the past.NCT05849220·New Delhi, National Capital Territory of Delhi

UnknownBariatric Endoscopy and NAFLDFind out how bariatric endoscopy will influence the clinical course of non-alcoholic fatty liver disease.NCT04895943·Ostrava, Moravian-Silesian Region

Active not recruitingEffects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B PatientsChronic hepatitis B (CHB) affects 257million individuals worldwide. In 2017, it caused around 39.7 million cases of cirrhosis and 0.4 million cirrhosis-related deaths in 2017.NCT05147090·Hong Kong, Hong Kong, China

RecruitingInAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerThis research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or has been diagnosed…NCT05463796·Boston, Massachusetts

CompletedEfficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic SteatohepatitisThe purpose of this interventional study is to evaluate the efficacy and tolerability of docosahexaenoic acid (DHA), Vitamin E and Choline in children or adolescents with…NCT01934777·Rome, Rome, Italy

PreviousPage 3 of 11Next